Generate Biomedicines, Inc. (GENB)
NGS · Common · CUSIP 370920100
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for GENB and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
370920100
IPO
2/27/2026 · $16.00/share
Business: Generate Biomedicines, Inc. is a clinical-stage generative biology company founded at the intersection of machine learning, biological engineering, and medicine, advancing a new era of programmable biology to engineer better medicines for patients

Company Contact

CEO
Michael Nally
CFO
Jason Silvers
Headquarters
101 South Street, Suite 900, Somerville, MA 02143
Phone
888-469-0055
Investor Relations
Jason Silvers · investors@generatebiomedicines.com
SEC EDGAR Filings
View filings »